Plain-English translation of NCT07651046 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether a special heart scan called cardiac computed tomography angiography (CCTA) can predict which patients will have the best outcomes after ablation surgery for atrial fibrillation. Atrial fibrillation is an irregular heartbeat condition, and while ablation is an effective treatment, some people experience the arrhythmia returning. This research aims to use detailed heart imaging to identify which patients are most likely to benefit from the procedure.
Currently, doctors have limited tools to predict which atrial fibrillation patients will do well after ablation and which ones may have the arrhythmia return. This study hopes to use heart imaging measurements to better predict outcomes, so doctors can identify patients who need additional treatment or closer monitoring.
You likely qualify if…
You likely don't qualify if…
You will have a heart scan (CCTA) before your ablation procedure to measure the size and function of your heart chambers. After your ablation surgery, you will be monitored for 12 months with follow-up visits or phone calls to check whether your atrial fibrillation returns. The study team will track any irregular heartbeats during this year of follow-up.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China
~600 participants
Started
August 2024
Primary completion
August 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lei Lv, MS
Nanjing First Hospital, Nanjing Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.